Literature DB >> 11104031

HSNF5/INI1 gene mutations in lymphoid malignancy.

M Yuge1, H Nagai, T Uchida, T Murate, Y Hayashi, T Hotta, H Saito, T Kinoshita.   

Abstract

hSNF5/INI1 is one of the components of the SWI/SNF multiprotein complex that is necessary for the transcriptional activation of several genes and functions by altering chromatin structure. This gene has been thought to be one of the tumor suppressor genes (TSGs) because deletions or mutations were reported in malignant rhabdoid tumors and atypical teratoid and rhabdoid tumors. To evaluate the hSNF5/INI1 gene as a TSG in lymphoid malignancies, we performed a mutational analysis in 23 patients with non-Hodgkin lymphoma (NHL), 24 with acute lymphoblastic leukemia (ALL), 24 with multiple myeloma (MM), 24 with adult T-cell lymphoma/leukemia (ATLL), and 19 with lymphoid cell lines, by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) analysis. Nonsense and missense mutations were found in 1 NHL case and 2 cell lines. Mutations from this NHL case proved to be somatic in origin. These data indicated that alterations in the hSNF5/INI1 gene might be involved in the pathogenesis of lymphoid malignancies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104031     DOI: 10.1016/s0165-4608(00)00274-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  HLTF gene silencing in human colon cancer.

Authors:  Helen R Moinova; Wei-Dong Chen; Lanlan Shen; Dominic Smiraglia; Joseph Olechnowicz; Lakshmeswari Ravi; Lakshmi Kasturi; Lois Myeroff; Christoph Plass; Ramon Parsons; John Minna; James K V Willson; Sylvan B Green; Jean-Pierre Issa; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 2.  Targeting EZH2 and PRC2 dependence as novel anticancer therapy.

Authors:  Bowen Xu; Kyle D Konze; Jian Jin; Gang Greg Wang
Journal:  Exp Hematol       Date:  2015-05-28       Impact factor: 3.084

3.  Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.

Authors:  Samantha G Pattenden; Robert Klose; Elizabeth Karaskov; Rod Bremner
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

4.  Molecular heterogeneity of meningioma with INI1 mutation.

Authors:  P Rieske; M Zakrzewska; S Piaskowski; D Jaskólski; B Sikorska; W Papierz; K Zakrzewski; P P Liberski
Journal:  Mol Pathol       Date:  2003-10

5.  Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.

Authors:  Supratik Das; Jennifer Cano; Ganjam V Kalpana
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

6.  Pediatric embryonal tumor with epithelial immunophenotype showing absence of hSNF5/INI1 expression.

Authors:  Keiichi Sakai; Hiroaki Shigeta; Yoshifumi Ogiso; Kazuhiro Hongo; Shigeaki Kobayashi; Takanori Hirose
Journal:  Childs Nerv Syst       Date:  2004-05-25       Impact factor: 1.475

7.  Lessons from senescence: Chromatin maintenance in non-proliferating cells.

Authors:  Taranjit Singh Rai; Peter D Adams
Journal:  Biochim Biophys Acta       Date:  2011-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.